{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:04:02Z","timestamp":1794405842095,"version":"4.9.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12035-011-8219-8","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T08:27:22Z","timestamp":1323332842000},"page":"87-98","source":"Crossref","is-referenced-by-count":63,"title":["Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington\u2019s Disease"],"prefix":"10.1007","volume":"45","author":[{"given":"Scott D.","family":"Olson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Kambal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Cary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaela-Marie","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Tempkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannine","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Sook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tempkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Wheelock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geralyn","family":"Annett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Nolta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,9]]},"reference":[{"key":"8219_CR1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/rme.10.72","volume":"5","author":"N Joyce","year":"2010","unstructured":"Joyce N, Annett G, Wirthlin L, Olson S, Bauer G, Nolta JA (2010) Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative med 5:933\u2013946","journal-title":"Regenerative med"},{"key":"8219_CR2","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","volume":"62","author":"T Meyerrose","year":"2010","unstructured":"Meyerrose T, Olson S, Pontow S, Kalomoiris S, Jung Y, Annett G, Bauer G, Nolta JA (2010) Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Adv drug deliv rev 62:1167\u20131174","journal-title":"Adv drug deliv rev"},{"key":"8219_CR3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/14653240601045399","volume":"8","author":"K Blanc Le","year":"2006","unstructured":"Le Blanc K (2006) Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8:559\u2013561","journal-title":"Cytotherapy"},{"key":"8219_CR4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB Jr, Reisman MA, Schaer GL, Sherman W (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277\u20132286","journal-title":"J Am Coll Cardiol"},{"key":"8219_CR5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/187152809788462635","volume":"8","author":"RE Newman","year":"2009","unstructured":"Newman RE, Yoo D, LeRoux MA, Danilkovitch-Miagkova A (2009) Treatment of inflammatory diseases with mesenchymal stem cells. Inflamm allergy drug targets 8:110\u2013123","journal-title":"Inflamm allergy drug targets"},{"key":"8219_CR6","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt1117","volume":"23","author":"MA Laflamme","year":"2005","unstructured":"Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23:845\u2013856","journal-title":"Nat Biotechnol"},{"key":"8219_CR7","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/jnr.10691","volume":"73","author":"J Chen","year":"2003","unstructured":"Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M (2003) Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73:778\u2013786","journal-title":"J Neurosci Res"},{"key":"8219_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/glia.20126","volume":"49","author":"Y Li","year":"2005","unstructured":"Li Y, Chen J, Zhang CL, Wang L, Lu D, Katakowski M, Gao Q, Shen LH, Zhang J, Lu M, Chopp M (2005) Gliosis and brain remodeling after treatment of stroke in rats with marrow stromal cells. Glia 49:407\u2013417","journal-title":"Glia"},{"key":"8219_CR9","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1002\/art.11365","volume":"48","author":"JM Murphy","year":"2003","unstructured":"Murphy JM, Fink DJ, Hunziker EB, Barry FP (2003) Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 48:3464\u20133474","journal-title":"Arthritis Rheum"},{"key":"8219_CR10","doi-asserted-by":"crossref","unstructured":"Rosova I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173\u20132182","DOI":"10.1634\/stemcells.2007-1104"},{"key":"8219_CR11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678\u2013685","journal-title":"Circ Res"},{"key":"8219_CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661\u2013669","journal-title":"FASEB J"},{"key":"8219_CR13","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.1182\/blood-2008-04-154567","volume":"113","author":"BJ Capoccia","year":"2009","unstructured":"Capoccia BJ, Robson DL, Levac KD, Maxwell DJ, Hohm SA, Neelamkavil MJ, Bell GI, Xenocostas A, Link DC, Piwnica-Worms D, Nolta JA, Hess DA (2009) Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity. Blood 113:5340\u20135351","journal-title":"Blood"},{"key":"8219_CR14","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1634\/stemcells.2007-1104","volume":"26","author":"I Rosova","year":"2008","unstructured":"Rosova I, Dao M, Capoccia B, Link D, Nolta JA (2008) Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26:2173\u20132182","journal-title":"Stem Cells"},{"key":"8219_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/01.TP.0000048488.35010.95","volume":"75","author":"GD Wu","year":"2003","unstructured":"Wu GD, Nolta JA, Jin YS, Barr ML, Yu H, Starnes VA, Cramer DV (2003) Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 75:679\u2013685","journal-title":"Transplantation"},{"key":"8219_CR16","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1634\/stemcells.2006-0243","volume":"25","author":"T Meyerrose","year":"2007","unstructured":"Meyerrose T, De Ugarte D, Hofling A, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA, Nolta JA (2007) In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models. Stem Cells 25:220\u2013227","journal-title":"Stem Cells"},{"key":"8219_CR17","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1634\/stemcells.2008-0008","volume":"26","author":"TE Meyerrose","year":"2008","unstructured":"Meyerrose TE, Roberts M, Ohlemiller KK, Vogler CA, Wirthlin L, Nolta JA, Sands MS (2008) Lentiviral-transduced human mesenchymal stem cells persistently express therapeutic levels of enzyme in a xenotransplantation model of human disease. Stem Cells 26:1713\u20131722","journal-title":"Stem Cells"},{"key":"8219_CR18","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/mt.2008.93","volume":"16","author":"G Bauer","year":"2008","unstructured":"Bauer G, Dao MA, Case SS, Meyerrose T, Wirthlin L, Zhou P, Wang X, Herrbrich P, Arevalo J, Csik S, Skelton DC, Walker J, Pepper K, Kohn DB, Nolta JA (2008) In vivo biosafety model to assess the risk of adverse events from retroviral and lentiviral vectors. Mol Ther 16:1308\u20131315","journal-title":"Mol Ther"},{"key":"8219_CR19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/stem.150443","volume":"15","author":"MA Dao","year":"1997","unstructured":"Dao MA, Pepper KA, Nolta JA (1997) Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells 15:443\u2013454","journal-title":"Stem Cells"},{"key":"8219_CR20","doi-asserted-by":"crossref","unstructured":"Nolta J (2006) Genetic Engineering of Mesenchymal Stem Cells: Kluwer.","DOI":"10.1007\/1-4020-3959-X"},{"key":"8219_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejcb.2009.02.001","volume":"88","author":"L Danielyan","year":"2009","unstructured":"Danielyan L, Schafer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T, Burkhardt U, Proksch B, Verleysdonk S, Ayturan M, Buniatian GH, Gleiter CH, Frey WH 2nd (2009) Intranasal delivery of cells to the brain. Eur j cell biol 88:315\u2013324","journal-title":"Eur j cell biol"},{"key":"8219_CR22","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1582-4934.2008.00657.x","volume":"13","author":"J Rossignol","year":"2009","unstructured":"Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, Dey ND, Boeffard F, Delecrin J, Heymann D, Vanhove B, Anegon I, Naveilhan P, Dunbar GL, Lescaudron L (2009) Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 13:2547\u20132558","journal-title":"J Cell Mol Med"},{"key":"8219_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.expneurol.2005.10.029","volume":"198","author":"L Crigler","year":"2006","unstructured":"Crigler L, Robey RC, Asawachaicharn A, Gaupp D, Phinney DG (2006) Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis. Exp Neurol 198:54\u201364","journal-title":"Exp Neurol"},{"key":"8219_CR24","doi-asserted-by":"crossref","first-page":"18171","DOI":"10.1073\/pnas.0508945102","volume":"102","author":"JR Munoz","year":"2005","unstructured":"Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem\/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 102:18171\u201318176","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8219_CR25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archneur.65.6.753","volume":"65","author":"I Kassis","year":"2008","unstructured":"Kassis I, Grigoriadis N, Gowda-Kurkalli B, Mizrachi-Kol R, Ben-Hur T, Slavin S, Abramsky O, Karussis D (2008) Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. Arch Neurol 65:753\u2013761","journal-title":"Arch Neurol"},{"key":"8219_CR26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1523\/JNEUROSCI.3566-10.2011","volume":"31","author":"SA Busch","year":"2011","unstructured":"Busch SA, Hamilton JA, Horn KP, Cuascut FX, Cutrone R, Lehman N, Deans RJ, Ting AE, Mays RW, Silver J (2011) Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury. J Neurosci 31:944\u2013953","journal-title":"J Neurosci"},{"key":"8219_CR27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.nbd.2008.05.016","volume":"31","author":"A Vercelli","year":"2008","unstructured":"Vercelli A, Mereuta OM, Garbossa D, Muraca G, Mareschi K, Rustichelli D, Ferrero I, Mazzini L, Madon E, Fagioli F (2008) Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 31:395\u2013405","journal-title":"Neurobiol Dis"},{"key":"8219_CR28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.expneurol.2008.07.011","volume":"213","author":"E Morita","year":"2008","unstructured":"Morita E, Watanabe Y, Ishimoto M, Nakano T, Kitayama M, Yasui K, Fukada Y, Doi K, Karunaratne A, Murrell WG, Sutharsan R, Mackay-Sim A, Hata Y, Nakashima K (2008) A novel cell transplantation protocol and its application to an ALS mouse model. Exp Neurol 213:431\u2013438","journal-title":"Exp Neurol"},{"key":"8219_CR29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/scd.2009.0264","volume":"19","author":"C Josse","year":"2010","unstructured":"Josse C, Schoemans R, Niessen NA, Delgaudine M, Hellin AC, Herens C, Delvenne P, Bours V (2010) Systematic chromosomal aberrations found in murine bone marrow-derived mesenchymal stem cells. Stem cells dev 19:1167\u20131173","journal-title":"Stem cells dev"},{"key":"8219_CR30","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1158\/0008-5472.CAN-08-4630","volume":"69","author":"GV Rosland","year":"2009","unstructured":"Rosland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lonning PE, Bjerkvig R, Schichor C (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331\u20135339","journal-title":"Cancer Res"},{"key":"8219_CR31","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1158\/0008-5472.CAN-10-1305","volume":"70","author":"A Torsvik","year":"2010","unstructured":"Torsvik A, Rosland GV, Svendsen A, Molven A, Immervoll H, McCormack E, Lonning PE, Primon M, Sobala E, Tonn JC, Goldbrunner R, Schichor C, Mysliwietz J, Lah TT, Motaln H, Knappskog S, Bjerkvig R (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track\u2014letter. Cancer Res 70:6393\u20136396","journal-title":"Cancer Res"},{"key":"8219_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2010.211","volume":"22","author":"YH Choi","year":"2011","unstructured":"Choi YH, Kurtz A, Stamm C (2011) Mesenchymal stem cells for cardiac cell therapy. Hum Gene Ther 22:3\u201317","journal-title":"Hum Gene Ther"},{"key":"8219_CR33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14712590902956615","volume":"9","author":"GW Dryden","year":"2009","unstructured":"Dryden GW (2009) Overview of stem cell therapy for Crohn\u2019s disease. Expert Opin Biol Ther 9:841\u2013847","journal-title":"Expert Opin Biol Ther"},{"key":"8219_CR34","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/14653249.2010.549688","volume":"13","author":"P Kebriaei","year":"2011","unstructured":"Kebriaei P, Robinson S (2011) Treatment of graft-versus-host-disease with mesenchymal stromal cells. Cytotherapy 13:262\u2013268","journal-title":"Cytotherapy"},{"key":"8219_CR35","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1378\/chest.10-0518","volume":"138","author":"MA Matthay","year":"2010","unstructured":"Matthay MA, Thompson BT, Read EJ, McKenna DH Jr, Liu KD, Calfee CS, Lee JW (2010) Therapeutic potential of mesenchymal stem cells for severe acute lung injury. Chest 138:965\u2013972","journal-title":"Chest"},{"key":"8219_CR36","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1111\/j.1582-4934.2009.00857.x","volume":"13","author":"NK Satija","year":"2009","unstructured":"Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, Afrin F, Sharma M, Sharma P, Tripathi RP, Gurudutta GU (2009) Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 13:4385\u20134402","journal-title":"J Cell Mol Med"},{"key":"8219_CR37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/13645700801969758","volume":"17","author":"D Spitkovsky","year":"2008","unstructured":"Spitkovsky D, Hescheler J (2008) Adult mesenchymal stromal stem cells for therapeutic applications. Minim Invasive Ther Allied Technol 17:79\u201390","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"8219_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/stem.570","volume":"29","author":"KT Wright","year":"2011","unstructured":"Wright KT, Masri WE, Osman A, Chowdhury J, Johnson WE (2011) Concise review: bone marrow for the treatment of spinal cord injury: mechanisms and clinical applications. Stem Cells 29:169\u2013178","journal-title":"Stem Cells"},{"key":"8219_CR39","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1002\/stem.187","volume":"27","author":"S Kidd","year":"2009","unstructured":"Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC (2009) Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27:2614\u20132623","journal-title":"Stem Cells"},{"key":"8219_CR40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14653240802486517","volume":"10","author":"S Kidd","year":"2008","unstructured":"Kidd S, Spaeth E, Klopp A, Andreeff M, Hall B, Marini FC (2008) The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10:657\u2013667","journal-title":"Cytotherapy"},{"key":"8219_CR41","doi-asserted-by":"crossref","unstructured":"Biglan KM, Ross CA, Langbehn DR, Aylward EH, Stout JC, Queller S, Carlozzi NE, Duff K, Beglinger LJ, Paulsen JS (2009) Motor abnormalities in premanifest persons with Huntington\u2019s disease: The PREDICT-HD study. Mov Disord 24:1763\u20131772","DOI":"10.1002\/mds.22601"},{"key":"8219_CR42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","volume":"59","author":"JS Paulsen","year":"2006","unstructured":"Paulsen JS, Magnotta VA, Mikos AE, Paulson HL, Penziner E, Andreasen NC, Nopoulos PC (2006) Brain structure in preclinical Huntington\u2019s disease. Biol Psychiatry 59:57\u201363","journal-title":"Biol Psychiatry"},{"key":"8219_CR43","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1634\/stemcells.2007-1047","volume":"27","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, McMillan E, Han F, Svendsen CN (2009) Regionally specified human neural progenitor cells derived from the mesencephalon and forebrain undergo increased neurogenesis following overexpression of ASCL1. Stem Cells 27:390\u2013398","journal-title":"Stem Cells"},{"key":"8219_CR44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neulet.2008.04.106","volume":"456","author":"J Sharp","year":"2009","unstructured":"Sharp J, Keirstead HS (2009) Stem cell-based cell replacement strategies for the central nervous system. Neurosci Lett 456:107\u2013111","journal-title":"Neurosci Lett"},{"key":"8219_CR45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/157488808783489471","volume":"3","author":"SA Hardy","year":"2008","unstructured":"Hardy SA, Maltman DJ, Przyborski SA (2008) Mesenchymal stem cells as mediators of neural differentiation. Curr stem cell res ther 3:43\u201352","journal-title":"Curr stem cell res ther"},{"key":"8219_CR46","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2202-10-16","volume":"10","author":"K Montzka","year":"2009","unstructured":"Montzka K, Lassonczyk N, Tschoke B, Neuss S, Fuhrmann T, Franzen R, Smeets R, Brook GA, Woltje M (2009) Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci 10:16","journal-title":"BMC Neurosci"},{"key":"8219_CR47","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cbf.1690","volume":"28","author":"PB Gahan","year":"2010","unstructured":"Gahan PB, Stroun M (2010) The virtosome\u2014a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct 28:529\u2013538","journal-title":"Cell Biochem Funct"},{"key":"8219_CR48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ceb.2008.03.005","volume":"20","author":"HH Gerdes","year":"2008","unstructured":"Gerdes HH, Carvalho RN (2008) Intercellular transfer mediated by tunneling nanotubes. Curr Opin Cell Biol 20:470\u2013475","journal-title":"Curr Opin Cell Biol"},{"key":"8219_CR49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ceb.2009.03.007","volume":"21","author":"M Simons","year":"2009","unstructured":"Simons M, Raposo G (2009) Exosomes\u2013vesicular carriers for intercellular communication. Curr Opin Cell Biol 21:575\u2013581","journal-title":"Curr Opin Cell Biol"},{"key":"8219_CR50","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1681\/ASN.2008070798","volume":"20","author":"S Bruno","year":"2009","unstructured":"Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati B, Tetta C, Camussi G (2009) Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053\u20131067","journal-title":"J Am Soc Nephrol"},{"key":"8219_CR51","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12015-008-9036-y","volume":"4","author":"PJ Quesenberry","year":"2008","unstructured":"Quesenberry PJ, Aliotta JM (2008) The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles. Stem Cell Rev 4:137\u2013147","journal-title":"Stem Cell Rev"},{"key":"8219_CR52","doi-asserted-by":"crossref","first-page":"e6219","DOI":"10.1371\/journal.pone.0006219","volume":"4","author":"AM Skinner","year":"2009","unstructured":"Skinner AM, O\u2019Neill SL, Kurre P (2009) Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells. PLoS One 4:e6219","journal-title":"PLoS One"},{"key":"8219_CR53","doi-asserted-by":"crossref","unstructured":"Taylor DD, Gercel-Taylor C (2011) Exosomes\/microvesicles: mediators of cancer-associated immunosuppressive microenvironments. Seminars Immunopathol 33:441\u2013454","DOI":"10.1007\/s00281-010-0234-8"},{"key":"8219_CR54","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/sj.leu.2404132","volume":"20","author":"J Ratajczak","year":"2006","unstructured":"Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, Ratajczak MZ (2006) Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20:847\u2013856","journal-title":"Leukemia"},{"key":"8219_CR55","doi-asserted-by":"crossref","unstructured":"Olson SD, Kambal A, Pollock K, Mitchell GM, Stewart H, Kalomoiris S, Cary W, Nacey C, Pepper K, Nolta JA (2011) Examination of Mesenchymal stem cell-mediated RNAi transfer to Huntington\u2019s disease affected neuronal cells for reduction of huntingtin. Molecular Neurology (in press)","DOI":"10.1016\/j.mcn.2011.12.001"},{"key":"8219_CR56","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1073\/pnas.0510511103","volume":"103","author":"JL Spees","year":"2006","unstructured":"Spees JL, Olson SD, Whitney MJ, Prockop DJ (2006) Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci U S A 103:1283\u20131288","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8219_CR57","unstructured":"Wilkins A, Kemp K, Ginty M, Hares K, Mallam E, Scolding N (2011) Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res"},{"key":"8219_CR58","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/jnr.22146","volume":"87","author":"I Aizman","year":"2009","unstructured":"Aizman I, Tate CC, McGrogan M, Case CC (2009) Extracellular matrix produced by bone marrow stromal cells and by their derivative, SB623 cells, supports neural cell growth. J Neurosci Res 87:3198\u20133206","journal-title":"J Neurosci Res"},{"key":"8219_CR59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2008.12.010","volume":"216","author":"AP Croft","year":"2009","unstructured":"Croft AP, Przyborski SA (2009) Mesenchymal stem cells expressing neural antigens instruct a neurogenic cell fate on neural stem cells. Exp Neurol 216:329\u2013341","journal-title":"Exp Neurol"},{"key":"8219_CR60","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.biomaterials.2009.11.084","volume":"31","author":"GJ Delcroix","year":"2010","unstructured":"Delcroix GJ, Schiller PC, Benoit JP, Montero-Menei CN (2010) Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials 31:2105\u20132120","journal-title":"Biomaterials"},{"key":"8219_CR61","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293:493\u2013498","journal-title":"Science"},{"key":"8219_CR62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato C, Valenza M, Cattaneo E (2010) Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiol Rev 90:905\u2013981","journal-title":"Physiol Rev"},{"key":"8219_CR63","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0306-4522(99)00296-1","volume":"93","author":"SD Croll","year":"1999","unstructured":"Croll SD, Suri C, Compton DL, Simmons MV, Yancopoulos GD, Lindsay RM, Wiegand SJ, Rudge JS, Scharfman HE (1999) Brain-derived neurotrophic factor transgenic mice exhibit passive avoidance deficits, increased seizure severity and in vitro hyperexcitability in the hippocampus and entorhinal cortex. Neuroscience 93:1491\u20131506","journal-title":"Neuroscience"},{"key":"8219_CR64","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ, Davidson BL (2009) Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther 17:1053\u20131063","journal-title":"Mol Ther"},{"key":"8219_CR65","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q, Yang L, Kotin RM, Paulson HL, Davidson BL (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci U S A 102:5820\u20135825","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8219_CR66","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","volume":"104","author":"M DiFiglia","year":"2007","unstructured":"DiFiglia M, Sena-Esteves M, Chase K, Sapp E, Pfister E, Sass M, Yoder J, Reeves P, Pandey RK, Rajeev KG, Manoharan M, Sah DW, Zamore PD, Aronin N (2007) Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits. Proc Natl Acad Sci U S A 104:17204\u201317209","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8219_CR67","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","volume":"53","author":"YL Wang","year":"2005","unstructured":"Wang YL, Liu W, Wada E, Murata M, Wada K, Kanazawa I (2005) Clinico-pathological rescue of a model mouse of Huntington\u2019s disease by siRNA. Neurosci Res 53:241\u2013249","journal-title":"Neurosci Res"},{"key":"8219_CR68","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.expneurol.2009.03.004","volume":"217","author":"MS Lombardi","year":"2009","unstructured":"Lombardi MS, Jaspers L, Spronkmans C, Gellera C, Taroni F, Di Maria E, Donato SD, Kaemmerer WF (2009) A majority of Huntington\u2019s disease patients may be treatable by individualized allele-specific RNA interference. Exp Neurol 217:312\u2013319","journal-title":"Exp Neurol"},{"key":"8219_CR69","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","volume":"19","author":"EL Pfister","year":"2009","unstructured":"Pfister EL, Kennington L, Straubhaar J, Wagh S, Liu W, DiFiglia M, Landwehrmeyer B, Vonsattel JP, Zamore PD, Aronin N (2009) Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington\u2019s disease patients. Curr Biol 19:774\u2013778","journal-title":"Curr Biol"},{"key":"8219_CR70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","volume":"108","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Engelman J, Friedlander RM (2009) Allele-specific silencing of mutant Huntington\u2019s disease gene. J Neurochem 108:82\u201390","journal-title":"J Neurochem"},{"key":"8219_CR71","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/00207450390207759","volume":"113","author":"L Lescaudron","year":"2003","unstructured":"Lescaudron L, Unni D, Dunbar GL (2003) Autologous adult bone marrow stem cell transplantation in an animal model of huntington\u2019s disease: behavioral and morphological outcomes. Int J Neurosci 113:945\u2013956","journal-title":"Int J Neurosci"},{"key":"8219_CR72","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.mcn.2007.11.001","volume":"37","author":"K Bantubungi","year":"2008","unstructured":"Bantubungi K, Blum D, Cuvelier L, Wislet-Gendebien S, Rogister B, Brouillet E, Schiffmann SN (2008) Stem cell factor and mesenchymal and neural stem cell transplantation in a rat model of Huntington\u2019s disease. Mol Cell Neurosci 37:454\u2013470","journal-title":"Mol Cell Neurosci"},{"key":"8219_CR73","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1179\/174313208X327955","volume":"30","author":"EM Amin","year":"2008","unstructured":"Amin EM, Reza BA, Morteza BR, Maryam MM, Ali M, Zeinab N (2008) Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res 30:1086\u20131090","journal-title":"Neurol Res"},{"key":"8219_CR74","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/096368970000900109","volume":"9","author":"C Watts","year":"2000","unstructured":"Watts C, McNamara IR, Dunnett SB (2000) Volume and differentiation of striatal grafts in rats: relationship to the number of cells implanted. Cell transplant 9:65\u201372","journal-title":"Cell transplant"},{"key":"8219_CR75","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbr.2010.05.023","volume":"214","author":"ND Dey","year":"2010","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav brain res 214:193\u2013200","journal-title":"Behav brain res"},{"key":"8219_CR76","doi-asserted-by":"crossref","unstructured":"Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M (2010) Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res 32:166\u2013172","DOI":"10.1179\/174313209X409025"},{"key":"8219_CR77","doi-asserted-by":"crossref","unstructured":"Im W, Lee ST, Park JE, Oh HJ, Shim J, Lim J, Chu K, Kim M (2010) Transplantation of patient-derived adipose stem cells in YAC128 Huntington\u2019s disease transgenic mice. PLoS Curr 2","DOI":"10.1371\/currents.RRN1183"},{"key":"8219_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1179\/016164110X12816242542571","volume":"33","author":"Y Jiang","year":"2011","unstructured":"Jiang Y, Lv H, Huang S, Tan H, Zhang Y, Li H (2011) Bone marrow mesenchymal stem cells can improve the motor function of a Huntington\u2019s disease rat model. Neurol Res 33:331\u2013337","journal-title":"Neurol Res"},{"key":"8219_CR79","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/ana.21788","volume":"66","author":"ST Lee","year":"2009","unstructured":"Lee ST, Chu K, Jung KH, Im WS, Park JE, Lim HC, Won CH, Shin SH, Lee SK, Kim M, Roh JK (2009) Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 66:671\u2013681","journal-title":"Ann Neurol"},{"key":"8219_CR80","doi-asserted-by":"crossref","first-page":"e22924","DOI":"10.1371\/journal.pone.0022924","volume":"6","author":"YT Lin","year":"2011","unstructured":"Lin YT, Chern Y, Shen CK, Wen HL, Chang YC, Li H, Cheng TH, Hsieh-Li HM (2011) Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington\u2019s disease mouse models. PLoS One 6:e22924","journal-title":"PLoS One"},{"key":"8219_CR81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.bbr.2010.11.006","volume":"217","author":"J Rossignol","year":"2011","unstructured":"Rossignol J, Boyer C, Leveque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L (2011) Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington\u2019s disease: morphological and behavioral outcomes. Behav brain res 217:369\u2013378","journal-title":"Behav brain res"},{"key":"8219_CR82","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1634\/stemcells.2008-0240","volume":"26","author":"O Sadan","year":"2008","unstructured":"Sadan O, Shemesh N, Barzilay R, Bahat-Stromza M, Melamed E, Cohen Y, Offen D (2008) Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells 26:2542\u20132551","journal-title":"Stem Cells"},{"key":"8219_CR83","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2008.12.013","volume":"1255","author":"GJ Delcroix","year":"2009","unstructured":"Delcroix GJ, Jacquart M, Lemaire L, Sindji L, Franconi F, Le Jeune JJ, Montero-Menei CN (2009) Mesenchymal and neural stem cells labeled with HEDP-coated SPIO nanoparticles: in vitro characterization and migration potential in rat brain. Brain res 1255:18\u201331","journal-title":"Brain res"},{"key":"8219_CR84","first-page":"201","volume":"11","author":"O Sadan","year":"2009","unstructured":"Sadan O, Shemesh N, Cohen Y, Melamed E, Offen D (2009) Adult neurotrophic factor-secreting stem cells: a potential novel therapy for neurodegenerative diseases. Isr Med Assoc J 11:201\u2013204","journal-title":"Isr Med Assoc J"},{"key":"8219_CR85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","volume":"5","author":"AC Bachoud-Levi","year":"2006","unstructured":"Bachoud-Levi AC, Gaura V, Brugieres P, Lefaucheur JP, Boisse MF, Maison P, Baudic S, Ribeiro MJ, Bourdet C, Remy P, Cesaro P, Hantraye P, Peschanski M (2006) Effect of fetal neural transplants in patients with Huntington\u2019s disease 6\u00a0years after surgery: a long-term follow-up study. Lancet Neurol 5:303\u2013309","journal-title":"Lancet Neurol"},{"key":"8219_CR86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","volume":"127","author":"V Gaura","year":"2004","unstructured":"Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, Brugieres P, Mangin JF, Boisse MF, Palfi S, Cesaro P, Samson Y, Hantraye P, Peschanski M, Remy P (2004) Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients. Brain 127:65\u201372","journal-title":"Brain"},{"key":"8219_CR87","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, Acheson AL, Lindsay RM, Wiegand SJ (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"key":"8219_CR88","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","volume":"24","author":"ZC Baquet","year":"2004","unstructured":"Baquet ZC, Gorski JA, Jones KR (2004) Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci 24:4250\u20134258","journal-title":"J Neurosci"},{"key":"8219_CR89","first-page":"311","volume":"5","author":"C Zuccato","year":"2009","unstructured":"Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat rev 5:311\u2013322","journal-title":"Nat rev"},{"key":"8219_CR90","doi-asserted-by":"crossref","unstructured":"Arregui L, Benitez JA, Razgado LF, Vergara P, Segovia J (2011) Adenoviral astrocyte-specific expression of BDNF in the striata of mice transgenic for Huntington\u2019s disease delays the onset of the motor phenotype. Cell Mol Neurobiol 31:1229\u20131243","DOI":"10.1007\/s10571-011-9725-y"},{"key":"8219_CR91","first-page":"195","volume":"146","author":"J Alberch","year":"2004","unstructured":"Alberch J, Perez-Navarro E, Canals JM (2004) Neurotrophic factors in Huntington\u2019s disease. Prog brain res 146:195\u2013229","journal-title":"Prog brain res"},{"key":"8219_CR92","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"8219_CR93","doi-asserted-by":"crossref","unstructured":"Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically-engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington\u2019s disease. Behav Brain Res 214:193\u2013200","DOI":"10.1016\/j.bbr.2010.05.023"},{"key":"8219_CR94","volume-title":"Establishment and transduction of primary human stromal\/mesenchymal stem cell monolayers, Vol. Chapter 2","author":"T Meyerrose","year":"2006","unstructured":"Meyerrose T, Rosova I, Dao M, Herrbrich P, Bauer G, Nolta J (2006) Establishment and transduction of primary human stromal\/mesenchymal stem cell monolayers, Vol. Chapter 2. Kluwer Academic, Dordrecht"},{"key":"8219_CR95","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.93.6.2414","volume":"93","author":"JA Nolta","year":"1996","unstructured":"Nolta JA, Dao MA, Wells S, Smogorzewska EM, Kohn DB (1996) Transduction of pluripotent human hematopoietic stem cells demonstrated by clonal analysis after engraftment in immune-deficient mice. Proc Natl Acad Sci U S A 93:2414\u20132419","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8219_CR96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/hum.1990.1.3-257","volume":"1","author":"JA Nolta","year":"1990","unstructured":"Nolta JA, Kohn DB (1990) Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1:257\u2013268","journal-title":"Hum Gene Ther"},{"key":"8219_CR97","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4049\/jimmunol.166.1.170","volume":"166","author":"E Tsark","year":"2001","unstructured":"Tsark E, Dao M, Wang X, Weinberg K, Nolta J (2001) IL-7 enhances the responsiveness of human T cells that develop in the bone marrow of athymic mice. J Immunol 166:170\u2013181","journal-title":"J Immunol"},{"issue":"10","key":"8219_CR98","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1182\/blood-2002-05-1338","volume":"101","author":"X Wang","year":"2003","unstructured":"Wang X, Ge S, McNamara G, Hao QL, Crooks GM, Nolta JA (2003) Albumin expressing hepatocyte-like cells develop in the livers of immune-deficient mice transmitted with highly purified human hematopoietic stem cells. Blood 101(10):4201\u20134208","journal-title":"Blood"},{"key":"8219_CR99","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1182\/blood.V83.10.3041.3041","volume":"83","author":"JA Nolta","year":"1994","unstructured":"Nolta JA, Hanley MB, Kohn DB (1994) Sustained human hematopoiesis in immunodeficient mice by cotransplantation of marrow stroma expressing human interleukin-3: analysis of gene transduction of long-lived progenitors. Blood 83:3041\u20133051","journal-title":"Blood"},{"key":"8219_CR100","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/14660820310014653","volume":"4","author":"L Mazzini","year":"2003","unstructured":"Mazzini L, Fagioli F, Boccaletti R, Mareschi K, Oliveri G, Olivieri C, Pastore I, Marasso R, Madon E (2003) Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 4:158\u2013161","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"8219_CR101","doi-asserted-by":"crossref","unstructured":"Mazzini L, Ferrero I, Luparello V, Rustichelli D, Gunetti M, Mareschi K, Testa L, Stecco A, Tarletti R, Miglioretti M, Fava E, Nasuelli N, Cisari C, Massara M, Vercelli R, Oggioni GD, Carriero A, Cantello R, Monaco F, Fagioli F (2010) Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Experimental Neurol 223:229\u2013237","DOI":"10.1016\/j.expneurol.2009.08.007"},{"key":"8219_CR102","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2007.05.005","volume":"265","author":"D Karussis","year":"2008","unstructured":"Karussis D, Kassis I, Kurkalli BG, Slavin S (2008) Immunomodulation and neuroprotection with mesenchymal bone marrow stem cells (MSCs): a proposed treatment for multiple sclerosis and other neuroimmunological\/neurodegenerative diseases. J Neurol Sci 265:131\u2013135","journal-title":"J Neurol Sci"},{"key":"8219_CR103","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","volume":"67","author":"D Karussis","year":"2010","unstructured":"Karussis D, Karageorgiou C, Vaknin-Dembinsky A, Gowda-Kurkalli B, Gomori JM, Kassis I, Bulte JW, Petrou P, Ben-Hur T, Abramsky O, Slavin S (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 67:1187\u20131194","journal-title":"Arch Neurol"},{"key":"8219_CR104","unstructured":"Karussis D (2010) \u201cmultiple sclerosis AND stem cell\u201d. ClinicalTrialsgov A service of the US National Institutes of Health"},{"key":"8219_CR105","first-page":"50","volume":"4","author":"MM Bonab","year":"2010","unstructured":"Bonab MM, Yazdanbakhsh S, Lofti J (2010) Does mesenchymal stem cell therapy help multiple sclerosis patients? Report of a pilot study. Iran J Immunol 4:50\u201357","journal-title":"Iran J Immunol"},{"key":"8219_CR106","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/1352458509104590","volume":"15","author":"J Liang","year":"2009","unstructured":"Liang J, Zhang H, Hua B, Wang H, Wang J, Han Z, Sun L (2009) Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis. Mult Scler 15:644\u2013646","journal-title":"Mult Scler"},{"key":"8219_CR107","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/1352458506071301","volume":"12","author":"R Saccardi","year":"2006","unstructured":"Saccardi R, Kozak T, Bocelli-Tyndall C, Fassas A, Kazis A, Havrdova E, Carreras E, Saiz A, Lowenberg B, te Boekhorst PA, Gualandio F, Openshaw H, Longo G, Pagliai F, Massacesi L, Deconink E, Ouyang J, Nagore FJ, Besalduch J, Lisukov IA, Bonini A, Merelli E, Slavino S, Gratwohl A, Passweg J, Tyndall A, Steck AJ, Andolina M, Capobianco M, Martin JL, Lugaresi A, Meucci G, Saez RA, Clark RE, Fernandez MN, Fouillard L, Herstenstein B, Koza V, Cocco E, Baurmann H, Mancardi GL (2006) Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler 12:814\u2013823","journal-title":"Mult Scler"},{"key":"8219_CR108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1080\/14653240701883061","volume":"10","author":"ZX Zhang","year":"2008","unstructured":"Zhang ZX, Guan LX, Zhang K, Zhang Q, Dai LJ (2008) A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy 10:134\u2013139","journal-title":"Cytotherapy"},{"key":"8219_CR109","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.trsl.2009.07.006","volume":"155","author":"NK Venkataramana","year":"2010","unstructured":"Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM (2010) Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson\u2019s disease. Transl Res 155:62\u201370","journal-title":"Transl Res"},{"key":"8219_CR110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14712598.7.2.173","volume":"7","author":"RW Mays","year":"2007","unstructured":"Mays RW, van\u2019t Hof W, Ting AE, Perry R, Deans R (2007) Development of adult pluripotent stem cell therapies for ischemic injury and disease. Expert Opin Biol Ther 7:173\u2013184","journal-title":"Expert Opin Biol Ther"},{"key":"8219_CR111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.critrevonc.2007.09.007","volume":"65","author":"AE Ting","year":"2008","unstructured":"Ting AE, Mays RW, Frey MR, Hof WV, Medicetty S, Deans R (2008) Therapeutic pathways of adult stem cell repair. Crit rev oncol\/hematol 65:81\u201393","journal-title":"Crit rev oncol\/hematol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12035-011-8219-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T12:38:45Z","timestamp":1593347925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-011-8219-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,9]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["8219"],"URL":"https:\/\/doi.org\/10.1007\/s12035-011-8219-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,9]]}}}